Sridhar Ramaswamy, MD
Metastatic cancers are the major reason for treatment failure in the clinic, but we lack a detailed understanding of how primary tumors metastasize, why these secondary tumors are relatively drug resistant, and what enables cancer cells to remain dormant and then cause disease relapse many years after apparently curative treatment. We are taking a multidisciplinary approach to attack these fundamental and related problems. Our major goal is to identify important cancer gene networks that are essential in human cancer progression, to guide the development and clinical use of new cancer drugs and diagnostics.
Sridhar Ramaswamy, M.D. is the Tucker Gosnell Investigator, Associate Professor of Medicine, and Attending Physician at the Massachusetts General Hospital Cancer Center and Harvard Medical School. He is also an Associate Member of the Broad Institute of MIT and Harvard.